ClC-5 Chloride Channel

📖 Wiki Page

protein1058 wordssynced 2026-04-02

...

ClC-5 Chloride Channel

ClC-5 (Chloride Channel Protein 5) is a chloride channel primarily expressed in kidney proximal tubules and intestinal epithelium. It is essential for proper endosomal function in renal cells and has been implicated in neurodegeneration through its role in endosomal trafficking.

--- [@gnther1998]

Overview

Introduction

ClC-5 is a member of the CLC chloride channel family, functioning primarily as a chloride/proton antiporter rather than a pure chloride channel[@miller2006]. It is predominantly expressed in kidney proximal tubules and intestinal epithelial cells, where it plays a critical role in receptor-mediated endocytosis[@gnther1998].

While classically considered a renal protein, emerging research suggests ClC-5 may have roles in neuronal tissues through its function in endosomal trafficking.

Structure

ClC-5 has the typical CLC architecture:

18 transmembrane helices organized into two pseudo-subunits
Dimeric structure with two independent pores
Critical "proton glutamate" residue (E211) that serves as the gating mechanism and proton transfer site
Intracellular N- and C-termini containing regulatory domains

The crystal structure of ClC-5 (PDB: 2J9L) revealed the dimeric architecture and the position of key regulatory residues[@dutzler2002].

Normal Function

Kidney Function

In the proximal tubule, ClC-5 is essential for:

Receptor-mediated endocytosis: Critical for reclaiming filtered proteins from the glomerular filtrate
Endosomal acidification: Works in conjunction with the vacuolar H+-ATPase to acidify endosomes
Protein reabsorption: Enables uptake of low molecular weight proteins including albumin, transferrin, and β2-microglobulin

Cellular Mechanism

Chloride influx into endosomes neutralizes the positive charge from proton pumping by the V-ATPase
This enables proper acidification and facilitates protein trafficking through the endosomal pathway
ClC-5 knockout mice show profound defects in proximal tubule endocytosis[@piwon2000]

Potential Neurological Function

While ClC-5 is not highly expressed in [neurons](/entities/neurons) under normal conditions:

May play a role in glial cell endosomal function
Could affect neuronal protein clearance through alterations in systemic kidney function
Uremic toxins from kidney dysfunction can affect neuronal function

Role in Neurodegenerative Diseases

Chronic Kidney Disease and Cognitive Decline

There is growing evidence linking kidney disease to cognitive impairment:

Uremic encephalopathy: Accumulation of toxins affects neuronal function
Vascular contributions: Shared risk factors between CKD and dementia
[Blood-brain barrier](/entities/blood-brain-barrier): Kidney dysfunction may affect BBB integrity

Alzheimer's Disease Connection

Endosomal dysfunction: Shared pathophysiology with AD
Reduced [Aβ](/proteins/amyloid-beta) clearance: Kidney disease may impair systemic Aβ clearance
Inflammation: Both conditions involve inflammatory pathways

Parkinson's Disease

[α-synuclein](/proteins/alpha-synuclein) clearance: Kidney function may affect systemic clearance
Levodopa metabolism: Altered pharmacokinetics in CKD patients

Role in Kidney Disease

Dent Disease

Dent disease is an X-linked inherited disorder caused by CLCN5 mutations:

Clinical Features

Low molecular weight proteinuria: Due to impaired proximal tubule reabsorption
Hypercalciuria: Elevated urinary calcium excretion
Nephrolithiasis: Kidney stone formation
Progressive renal failure: Leading to end-stage renal disease
Rickets: In childhood cases (hypophosphatemic rickets)

Pathophysiology

Loss of ClC-5 function in proximal tubule cells

Impaired endosomal acidification

Failure to reclaim filtered proteins and minerals

Progressive tubular dysfunction

Development of kidney stones and renal failure

Other Renal Disorders

Fanconi syndrome: Generalized proximal tubule dysfunction
Idiopathic low molecular weight proteinuria
Focal segmental glomerulosclerosis (FSGS) - some cases

Genetics

The CLCN5 gene is located on chromosome Xp11.23 and contains 11 exons. Over 200 pathogenic variants have been described:

Nonsense mutations: Leading to truncated non-functional proteins (most common)
Missense mutations: Often affecting the pore region or gating mechanism
Frameshift mutations: Causing complete loss of function
Splice site mutations: Leading to exon skipping

Therapeutic Approaches

Current Management

Supportive care: Management of symptoms and complications
Stone prevention: Hydration, dietary modifications
Renal protection: ACE inhibitors or ARBs to slow progression
Dialysis: For end-stage renal disease
Transplantation: Kidney transplantation for ESRD

Investigational Therapies

Gene therapy: Viral vector-mediated CLCN5 delivery (preclinical)
Pharmacological chaperones: Small molecules to restore channel function
CRISPR-based approaches: Gene editing for permanent correction

Animal Models

Knockout Mice

ClC-5 knockout mice replicate the Dent disease phenotype:

Severe low molecular weight proteinuria
Hypercalciuria
Progressive renal failure
Impaired vitamin D metabolism

Transgenic Models

Conditional knockout models to study tissue-specific function
Humanized mouse models with patient-derived mutations

Interactions and Pathways

ClC-5 interacts with several key proteins:

Vacuolar H+-ATPase: Couples proton pumping to chloride influx
Cubilin: Co-receptor for protein reabsorption in proximal tubules
Megalin: Multi-ligand receptor for endocytosis
Retromer complex: Involved in endosomal sorting

[CLCN5 Gene](/genes/clcn5)
[Dent Disease](/diseases/dent-disease)
[ClC-4 Protein](/proteins/clcn4-protein)
[ClC-3 Protein](/proteins/clcn3-protein)
[ClC-7 Protein](/proteins/clcn7-protein)
[Kidney Disease and Neurodegeneration](/mechanisms/kidney-brain-axis)
[Endosomal Trafficking](/mechanisms/endosomal-trafficking)mechanisms/endosomal-lysosomal-pathway)

External Links

UniProt: [P51795](https://www.uniprot.org/uniprot/P51795)
PDB: [2J9L](https://www.rcsb.org/structure/2J9L)
NCBI Gene: [CLCN5](https://www.ncbi.nlm.nih.gov/gene/1185)
OMIM: [300009](https://omim.org/entry/300009)
NCBI ClinVar: [CLCN5 variants](https://www.ncbi.nlm.nih.gov/clinvar/?term=CLCN5)
KDIGO Guidelines: [Dent Disease Clinical Practice Guidelines](https://kdigo.org/)

Background

The study of Clc 5 Chloride Channel has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Miller C, (2006) (2006)](https://doi.org/10.1007/s00232-007-9021-4)

[Günther W, et al, (1998) (1998)](https://doi.org/10.1007/s004240050684)

[Dutzler R, et al, (2002) (2002)](https://doi.org/10.1038/415287a)

[Piwon N, et al, (2000) (2000)](https://doi.org/10.1038/35005092)

[Devuyst O & Thakker RV, (2010) (2010)](https://doi.org/10.1186/1750-1172-5-28)

[Lloyd SE, et al, (1996) (1996)](https://doi.org/10.1038/ng0196-49)

[Wrong OM, et al, (1994) (1994)](https://doi.org/10.1093/oxfordjournals.qjmed.a068956)

[Edwardson JM, et al, (2019) (2019)](https://doi.org/10.1007/s00467-018-4091-1)

📖 View canonical wiki page →

ClC-5 Chloride Channel